Published February 12, 2010 | Version v1
Journal article

IL-1-induced ERK1/2 activation up-regulates p21Waf1/Cip1 protein by inhibition of degradation via ubiquitin-independent pathway in human melanoma cells A375

  • 1. Department of Molecular Health Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603 (Japan)
  • 2. Department of Drug Metabolism and Disposition, Graduate School of Pharmaceutical Sciences, Nagoya City University, Nagoya 467-8603 (Japan)

Description

IL-1 inhibits the proliferation of human melanoma cells A375 by arresting the cell cycle at G0/G1 phase, which accompanies the increase of p21Waf1/Cip1 (p21) protein. Here, we demonstrate that IL-1 induces the stabilization of p21 protein via ERK1/2 pathway. The degradation of p21 was inhibited by IL-1, however the ubiquitination level of p21 was not affected. In addition, the degradation of non-ubiquitinated form of lysine less mutant p21-K6R was also inhibited by IL-1, suggesting that IL-1 stabilized p21 protein via ubiquitin-independent pathway. Furthermore, the inhibition of p21 protein degradation was prevented by a selective inhibitor of ERK1/2 pathway, PD98059. These results suggest that IL-1-induced ERK1/2 activation leads to the up-regulation of p21 by inhibiting degradation via ubiquitin-independent pathway in human melanoma cells A375.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2010.01.027

Additional details

Identifiers

DOI
10.1016/j.bbrc.2010.01.027;
PII
S0006-291X(10)00057-4;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
392
Journal Issue
3
Journal Page Range
p. 369-372
ISSN
0006-291X
CODEN
BBRCA9

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
45023282
Subject category
S60: APPLIED LIFE SCIENCES;
Descriptors DEI
CELL CYCLE; CELL PROLIFERATION; INHIBITION; LYSINE; MELANOMAS; MUTANTS; PROTEINS
Descriptors DEC
AMINO ACIDS; CARBOXYLIC ACIDS; CARCINOMAS; DISEASES; EPITHELIOMAS; NEOPLASMS; ORGANIC ACIDS; ORGANIC COMPOUNDS

Optional Information

Copyright
Copyright (c) 2010 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.